FDA authorizes use of bivalent mRNA COVID-19 vaccines, monovalent rescinded

SILVER SPRING, MD, April 18, 2023—The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule for most individuals. This action includes authorizing the current bivalent vaccines (original and omicron BA.4/BA.5 strains) to be used for all doses administered […]

FDA Approves First COVID-19 Vaccine

SILVER SPRING, MD, August, 23, 2021 – Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease in individuals 16 years of age and older. The vaccine also continues […]

Vaccine mandate conflicts with FDA approval requirements

OLYMPIA, Wash., August 19, 2021 — Yesterday, Gov. Jay Inslee announced a new vaccine mandate for all public education employees in Washington in light of the Delta variant’s spread. By October 18th, all education personnel must be fully vaccinated. He also reinstated an indoor mask mandate for the general public, which will go into effect […]